期刊文献+

加味止嗽散不同部位群对过敏性哮喘豚鼠平喘作用的比较 被引量:1

Experimental Study on Treatment of Allergic Asthma Guinea Pigs with Different Fractions of Modified Zhisousan
下载PDF
导出
摘要 目的:观察加味止嗽散(MZ)、MZ脂溶性部位群(MZC)和水溶性部位群(MZS)对过敏性哮喘豚鼠血液和支气管肺泡灌洗液(BALF)中嗜酸粒细胞(EOS)、内皮素-1(ET-1)、一氧化氮(NO)含量及对肺组织结构的影响。方法:采用Wright染色法计血液和BALF中的EOS。采用放射免疫法和硝酸还原酶法分别测定哮喘豚鼠血清和BALF中ET-1、NO的含量。光镜和电镜下观察豚鼠肺组织的结构变化。结果:哮喘模型组豚鼠体内的EOS、ET-1、NO的量明显高于正常对照组(P<0.01),肺组织病理学和超微结构发生明显改变。与哮喘模型组比较,MZ和MZC治疗组能降低豚鼠血液和BALF中EOS、ET-1、NO的含量(P<0.01或P<0.01)和减轻肺组织病理改变,MZS组则未见有明显的作用。结论:MZ中具有平喘作用的物质大多数集中在MZC中,其平喘作用机制可能与其能减少哮喘豚鼠体内EOS数量、恢复ET-1、NO平衡和减轻肺组织结构损伤有关。 Objective : To study the effects of different fractions of Modified Zhisousan ( MZ, MZC, MZS) on the contents of nitric oxide (NO), endothelin-1 (ET-1) and eosinophilia (EOS) in the allergic asthma guinea pigs and observe the pathology changes of lung tissue, Methods: The number of EOS in the blood and bronchialveolar lavage fluid (BALF) was counted by Wright staining. The contents of ET-I and No in serum and BALF were analyzed by RIA and nitric acid reductase method. The guinea pig lungs were ob- served under the optical and electron microscope. Results: The number of EOS and the contents of ET-1 and NO in model group were higher than those in control group ( P 〈 0.01 ). The pathological changes of lung were obvious. The number of EOS and the contents of ET-1 and NO were descended remarkably ( P 〈 0.05 or P 〈 0. 01 ) and the pathological changes in the lung tissue were lightened obviously in MZ and MZC groups, but MZS group had no such effects. Conclusion : MZC is the effective part of MZ and the anti-asthmatic mechanisms ware related to its significant reduction in contents of ET-1, NO, EOS and the damage of lung tissue possibly.
出处 《中药材》 CAS CSCD 北大核心 2006年第5期462-464,共3页 Journal of Chinese Medicinal Materials
关键词 哮喘 内皮素-1 一氧化氮 嗜酸粒细胞 加味止嗽散有效部位群 Asthma Endothelin-1 Nitric oxide Eosinophilias Effective fractions of Modified Zhisousan
  • 相关文献

参考文献6

二级参考文献10

  • 1杨映波,第三军医大学学报,1990年,12卷,209页 被引量:1
  • 2舒茂琴,中华结核和呼吸杂志,1993年,16卷,30页 被引量:1
  • 3杨玉,中华结核和呼吸杂志,1993年,16卷,30页 被引量:1
  • 4周史琴,中药学,1990年 被引量:1
  • 5徐叔云,药理实验方法学,1982年 被引量:1
  • 6Pedersen BK,Laursen LC,Gnosspelius Y,et al. Bambuterol:effects of a new anti-asthmatic drug. Eur J Clin Pharmacol,1985;29:425 被引量:1
  • 7Holstein-Rathlou NH,Laursen LC,Madsen F,et al. Bambuterol: dose-response study of a new terbutaline prodrug in asthma. Eur J Clin Pharmacol,1986;30:7 被引量:1
  • 8Sitar DS,Warren CP,Aoki FY. Pharmacokinetics and pharmacodynamics of bambuterol,a long-acting bronchodilator pro-drug of terbutaline,in young and elderly patients with asthma. Clin Pharmacol Ther,1992;52:297 被引量:1
  • 9Sitar DS, Aoki FY, Warren CP, et al. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest,1993;103:771 被引量:1
  • 10D'alonzo GE,Smolensky MH,Feldman S,et al. Bambuterol in the treatment of asthma: a placebocontrolled comparison of once-daily morning vs evening administration. Chest,1995;107:406 被引量:1

共引文献141

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部